EarliTec Diagnostics is a digital health company making earlier identification and treatment for ASD and related disabilities accessible to children everywhere. Developed by leading researchers at Children's Healthcare of Atlanta, Emory University School of Medicine and Yale University, EarliTec is pioneering development of biomarkers that help parents, providers and caregivers understand how a child is viewing the world.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/18/22 | $19,500,000 | Series A |
Bernie Marcus Georgia Research Alliance | undisclosed |
| 04/02/24 | $21,500,000 | Series B |
Nexus NeuroTech Ventures Venture Investors | undisclosed |
